2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Completed
10
Terminated
5
Withdrawn
3
Unknown
3
Recruiting
2
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
1789
Neoplasms
1516
Carcinoma, Non-Small-Cell Lung
1053
Prostatic Neoplasms
965
Colorectal Neoplasms
889
Lung Neoplasms
809
Pancreatic Neoplasms
583
Carcinoma, Hepatocellular
543
Leukemia, Myeloid, Acute
540
Stomach Neoplasms
523
Ovarian Neoplasms
513
Neoplasm Metastasis
492
Multiple Myeloma
491
Recurrence
417
Melanoma
390
Squamous Cell Carcinoma of Head and Neck
374
Uterine Cervical Neoplasms
366
Brain Neoplasms
364
Head and Neck Neoplasms
355
Esophageal Neoplasms
320
Precursor Cell Lymphoblastic Leukemia-Lymphoma
313
Endometrial Neoplasms
311
Lymphoma
309
Triple Negative Breast Neoplasms
301
Glioblastoma
298
Rectal Neoplasms
284
Urinary Bladder Neoplasms
268
Sarcoma
266
Hematologic Neoplasms
266
Colonic Neoplasms
257
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Hyperglycemia
×
Clear all
NCT05455619
2026-04-22
Amelia-1
SynDevRx, Inc.
Phase 1/2
Recruiting
52 enrolled
NCT05132244
2025-09-22
PEGASUS
British Columbia Cancer Agency
Phase NA
Recruiting
50 enrolled